Acute cardiovascular effects of apelin in humans: potential role in patients with chronic heart failure

A G Japp, N L Cruden, G Barnes, N van Gemeren, J Mathews, J Adamson, N R Johnston, M A Denvir, I L Megson, A D Flapan, D E Newby

Research output: Contribution to journalArticle

188 Citations (Scopus)

Abstract

Apelin, the endogenous ligand for the novel G protein-coupled receptor APJ, has major cardiovascular effects in preclinical models. The study objectives were to establish the effects of acute apelin administration on peripheral, cardiac, and systemic hemodynamic variables in healthy volunteers and patients with heart failure.
Original languageEnglish
Pages (from-to)1818-27
Number of pages10
JournalCirculation
Volume121
Issue number16
DOIs
Publication statusPublished - 2010

Fingerprint Dive into the research topics of 'Acute cardiovascular effects of apelin in humans: potential role in patients with chronic heart failure'. Together they form a unique fingerprint.

  • Cite this

    Japp, A. G., Cruden, N. L., Barnes, G., van Gemeren, N., Mathews, J., Adamson, J., Johnston, N. R., Denvir, M. A., Megson, I. L., Flapan, A. D., & Newby, D. E. (2010). Acute cardiovascular effects of apelin in humans: potential role in patients with chronic heart failure. Circulation, 121(16), 1818-27. https://doi.org/10.1161/CIRCULATIONAHA.109.911339